1Romberg E.Ubor sklerose der lungen arterie[J].Dtsch Arch Klin Med,1891,48:197[in German].
2Naeije R,Vachiery JL.Medical therapy of pulmonary hypertension:conventional therapies[J].Clin Chest Med,2001,22(3):517.
3Fuster V,Steele PM,Edwards WD,el al.Primary pulmonary hypertension:natural history and the importance of thrombosis[J].Circulation,1984,70(4):580.
4Kawut SM,Horn EM,Berekashvili KK,el al.New predictors of outcome in idiopathic pulmonary arterial hypertension[J].Am J Cardiol,2005,95(2):199.
5Rich S,Kaufmann E,Levy PS.The effect of high doses of calcium-channel blockers on survival in prinlary pulmonary hypertension[J].N Engl J Med,1992,327(2):76.
6Long term domiciliary oxygen therapy in chronic hypoxie cor pulmonale complicating chronic bronchitis and emphysema.Report of the Medical Reserch Council Working Party[J].Lancet,1981,1(8222):681.
7Nocturnal Oxygen Therapy Trial Group.Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease:a clinical trial[J].Ann Intern Med,1980,93(3):391.
8Sandoval J,Aguirre JS,Pulido T,et al.Noctunal oxygen therapy in patients with the Eisenmenger syndrome[J].Am J Respir Crit Care Med,2001,164(9):1 682.
9Bowyer JJ,Busst CM,Denisen DM,et al.Effect oflong term oxygen treatment at home in children with pulmonary vascular disease[J].Br Heart J,1986,80(5):807.
10Widlitz A,Barst RJ.Pulmonary arterial hypertionsion in children[J].Eur Respir J,2003,21(1):155.
5Sablotzki A, Hent schel T, Hofmann S ,et al. Inhaled aerosolized iloprost in t he evaluation of heart t ransplant candidates -experiences with 45 cases. J Clin Anesth,2006,18 : 1082113.
6Peter N K. Simvastatin t reatment of pulmonary hypertension: an observational case serieS. Chest, 2005,127 : 1446 - 1452.
7Ishikura K, Yamada N, ItO M, et al. Beneficial acute effect s of Rho2kinase inhibitor in patient s wit h pulmonary arterial hy2pertension. Circ J, 2006., 70 : 1742178.
8Stenmark KR, McMurt ry IF. Vascular remodeling versus vasoconst fiction in chronic hypoxic pulmonary hypertension: Atime for reappraisal. Cir Res, 2005, 97:95298.
93rd World PAH Symposium. Pulmonary arterial hypertension: epidemiology, pat hobiology, assessment and therapy. J Am Coll Cardiol,2004,43 : 1290.
10Marcos E, Adnot S, Pham MH, et al. Serotonin transporter inhibitors protectagainst hypoxic pulmonary hypertension. Am J Respir Crit Care Med, 2003, 168 (3) :487-493.
